Mortality rate within 30 days after embolization was 9/21 (42.8%), 2 patients had poor prognosis due to tumor progression without rebleeding, the remaining patients was affected by underlying diseases, coagulation disorders, death leaded by hemorrhagic shock or multiple organ failure.